Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ITRM
#3825
Iterum Therapeutics plc Ordinary Share
0.2
6
+13.04%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+13.04%
Changement Mensuel
-21.21%
Evolution sur 6 mois
-63.38%
Changement Annuel
-80.60%
Clôture Précédente
0.2
3
Open
0.2
6
Bid
Ask
Low
0.2
6
High
0.2
6
Volume
2
Marchés
Actions des Marchés US
Soins de Santé
ITRM
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
11.77 M
12.19 M
12.71 M
16.43 M
34.58 M
—
Valuation ratios
Enterprise value
—
—
-9.4 M
26.37 M
37.08 M
—
Price to earnings ratio
—
—
-0.25
-0.67
-1.4
-4.91
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
-0.61
-0.65
-1.3
-5.47
Price to book ratio
—
—
0.4
-4
-8.54
-11.42
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
1.59
1
0.66
1.46
0.56
0.76
Return on equity %
1.03
1.82
1.59
5.99
6.07
6.42
Return on invested capital %
354.99
284.57
960.67
4 974.98
420.29
390.3
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
0.51
6.43
6.89
1.89
1.41
9.46
Current ratio
0.51
6.43
6.89
1.89
1.41
9.96
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.68
0.08
0.15
0.44
0.7
2.52
Long term debt to total equity ratio
0.44
0.14
0.36
1.79
7.65
23.41
Per share metrics
Operating cash flow per share
—
—
1.51
3.03
1.36
0.59
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
4.97
1.85
1.22
2.16
Net current asset value per share
—
—
5.1
1.97
1.26
2.33
Tangible book value per share
—
—
2.15
0.49
-0.8
-1.92
Working capital per share
—
—
4.36
0.93
0.36
1.05
Book value per share
—
—
2.29
0.49
0.21
0.54
Nouvelles
Iterum Therapeutics élargit l’accès Medicare Part D pour ORLYNVAH
Iterum Therapeutics expands Medicare Part D access for ORLYNVAH
Iterum Therapeutics expands market access for ORLYNVAH antibiotic
Iterum Therapeutics conclut un accord majeur avec un GBM pour son antibiotique
Iterum Therapeutics secures major PBM agreement for antibiotic
Iterum Therapeutics reçoit un avis du Nasdaq concernant sa conformité de cotation
Iterum Therapeutics receives Nasdaq notice on listing compliance
Iterum Therapeutics étend la couverture de remboursement pour ORLYNVAH
Iterum Therapeutics expands reimbursement coverage for ORLYNVAH
Iterum’s antibiotic ORLYNVAH now available through McKesson
Le directeur d’Iterum Therapeutics, Dunne, achète des actions pour 2.191€
Iterum Therapeutics director Dunne buys $2,191 in shares